Discover
KTTA
Pasithea Therapeutics Corp.
0.57
2 x 0.42
2 x 0.66
bid
ask
+
0.05
9.99%
2 @ 06:00 AM
0.55 -0.01 (2.45%)
| Ytd | -56.05% | |
| 1y | -22.87% |
0.50
day range
0.61
0.28
52 week range
2.06
| Open | 0.50 | Prev Close | 0.52 | Low | 0.50 | High | 0.61 | Mkt Cap | 18.94M |
| Vol | 1.42M | Avg Vol | 862.61K | EPS | -1.42 | P/E | N/A | Forward P/E | -3.75 |
| Beta | 0.82 | Short Ratio | 0.32 | Inst. Own | 2.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-16 | 50-d Avg | 0.67 | 200-d Avg | 0.80 | 1yr Est | 2.00 |
| Income Statement | |||
| Operating Expenses | 4.88M | ||
| Research and Development Expense | 2.94M | ||
| Selling, General and Administrative Expense | 1.93M | ||
| Operating Income | -4.88M | ||
| Net Income | -2.87M | ||
| Net Income Common Stock | -2.87M | ||
| Net Income Common Stock (USD) | -2.87M | ||
| Consolidated Income | -2.87M | ||
| Earnings per Basic Share | -0.12 | ||
| Earnings per Basic Share (USD) | -0.12 | ||
| Earnings per Diluted Share | -0.12 | ||
| Earning Before Interest & Taxes (EBIT) | -2.87M | ||
| Earning Before Interest & Taxes (USD) | -2.87M | ||
| Weighted Average Shares | 24.34M | ||
| Weighted Average Shares Diluted | 24.34M | ||
| Balance Sheet | |||
| Cash and Equivalents | 50.50M | ||
| Cash and Equivalents (USD) | 50.50M | ||
| Current Assets | 52.73M | ||
| Total Assets | 56.35M | ||
| Current Liabilities | 1.49M | ||
| Total Liabilities | 1.54M | ||
| Accumulated Retained Earnings (Deficit) | -72.88M | ||
| Accumulated Other Comprehensive Income | 46.90K | ||
| Shareholders Equity | 54.81M | ||
| Shareholders Equity (USD) | 54.81M | ||
| Assets Non-Current | 3.62M | ||
| Goodwill and Intangible Assets | 3.62M | ||
| Liabilities Non-Current | 52.97K | ||
| Trade and Non-Trade Payables | 1.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 157.54K | ||
| Net Cash Flow from Financing | 750.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.76M | ||
| Issuance (Purchase) of Equity Shares | 750.00 | ||
| Net Cash Flow from Operations | -4.79M | ||
| Effect of Exchange Rate Changes on Cash | 28.13K | ||
| Share Based Compensation | 139.18K | ||